Young Donor Plasma Transfusion and Age-Related Biomarkers

NCT02803554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-05-11

No results posted yet for this study

Summary

The purpose of the study is to evaluate the beneficial effects of infusions of plasma from young donors using blood biomarkers.

Conditions

  • Aging

Interventions

OTHER

Plasma

Blood plasma from donors aged 25 years or younger

Sponsors & Collaborators

  • Ambrosia LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-01-15
Completion
2018-01-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02803554 on ClinicalTrials.gov